Gary Samoriski

Background

About Gary Samoriski

R&D professional and project management executive with over 20 years of pharmaceutical and management experience in global product development and the scientific evaluation of innovative new therapies ranging from pre-clinical to marketed products across multiple therapeutic areas, including Neurology/Rare Diseases, Oncology, Immunology, Gastroenterology, Dermatology, Women’s Health, Ophthalmology and Medical Aesthetics. Due Diligence Extensive experience in leading large multidisciplinary teams throughout the technical due diligence process resulting in a number of successful M&A, in-/out-license, and partnership deals. Skilled in working with the diligence teams to “stress test” content of diligence findings and the estimated impact of key technical risks and regulatory gaps on PTRS, Target Product Profile, timelines and budgets. Delivered integrated diligence reports to R&D Leadership and Business Development to drive efficient and effective decision-making. Global Product Development Expertise in all phases of pre-approval, post-approval and life-cycle drug development. Leader of cross-functional product development teams with experience in the planning and execution of integrated development plans resulting in successful global registration. Core Team Leader for a key Allergan GI asset (Viberzi) responsible for establishing and executing on the development strategy in alignment with the organization’s global objectives. Pharmacology Skilled in evaluating scientific data, analyzing the technical determinants of project success (e.g, principles of target engagement), performing risk/benefit analyses and identifying key therapeutic differentiators of new drug products (small molecules and biologics). Leadership Highly skilled at building a collaborative environment with internal teams and with potential partners which led to successful strategic business relationships. Provided support for the transition of asset development and regulatory responsibilities from Innovator to Allergan.